About Heading Health: Heading is on a mission to offer transformative mental health outcomes for all. We have designed an outcomes-led approach, pairing clinician know-how with interventional treatments that when paired with talk therapy significantly improve outcomes for chronic depression, PTSD and other anxiety cases in adults. The existing somatic treatments are Spravato (esketamine) and ketamine, with further neurostimulation and psychedelic therapies likely to be approved and covered by insurance in the coming years (MDMA, SAINT TMS protocol, psilocybin, and others)
Heading Health’s Mental Health Destination: Mental health care is often inaccessible, unaffordable, and is so often ineffective. At Heading Health, we utilize developments in clinical research, insurance coverage, and a software backbone to deliver the best outcomes for our patients.
How Heading Health Will Lead the Future of Mental Health: The secret sauce has been and always will be our rapid acting clinical care model which gets patients better faster. We have unmatched experience in delivering safe, effective interventional treatments and are guided by world leaders in clinical research and care delivery.
Heading Health PMHNP basics
Important to you
Heading Core Values
Qualifications
Compensation & benefits
Heading Health is on a mission to accelerate mental well-being through connection-based care. Our co-founder, Steve Levine MD, has designed an outcomes-led approach pairing clinician know-how with a new class of psychotherapy-assisted treatments that offer 3X better outcomes than second-line SSRI’s. These already FDA-approved treatments are Spravato, Transcranial Magnetic Stimulation (TMS), and ketamine, with psychedelic-assisted therapies (MDMA, psilocybin) likely to be approved over the coming years.
This site is only intended for job seekers to contact the organizations posting jobs. Use of this site for solicitation and other unintended purposes is prohibited.